The Veteran's service-connected non-Hodgkin's lymphoma was reduced from 100% to noncompensable. Separate evaluations of 20% were granted for peripheral neuropathy of the bilateral upper and lower extremities as residuals of NHL. A TDIU was also granted effective April 1, 2011.
The deciding factor: The reduction in NHL evaluation was proper due to remission without local recurrence or metastasis. The Veteran's peripheral neuropathy is at least as likely as not manifested by mild incomplete paralysis of the radial nerve and moderate incomplete paralysis of the sciatic nerve throughout the appeal period, warranting separate 20% evaluations.
- Claimed conditions
- Non-Hodgkin's Lymphoma, Peripheral Neuropathy (left upper extremity), Peripheral Neuropathy (right upper extremity), Peripheral Neuropathy (left lower extremity), Peripheral Neuropathy (right lower extremity)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 20%
- Decision date
- September 7, 2018
- Citation
- 18133149
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18133149.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's service connection for leukemia, characterized as CLL, was improperly severed. Service connection for T-cell LGL leukemia is restored. The severance of service connection for NHL is upheld.
- Granted
The Board has restored a 100 percent rating for the Veteran's non-Hodgkin's lymphoma, effective April 1, 2025.
- Granted
The Veteran's SMC was granted at the intermediate level between 38 U.S.C. § 1114(m) and (n) due to additional disabilities including peripheral neuropathies, tinnitus, hearing loss, and lymphoma.
- Granted
The Veteran's non-Hodgkin's Lymphoma was granted a 100% rating effective February 8, 2019.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.